98 related articles for article (PubMed ID: 15557368)
21. Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells.
Lamon BD; Summers BD; Gotto AM; Hajjar DP
Eur J Pharmacol; 2009 Mar; 606(1-3):72-6. PubMed ID: 19374880
[TBL] [Abstract][Full Text] [Related]
22. Influence of aspirin on SR-BI expression in human carotid plaques.
Wehinger A; Tancevski I; Seiler R; Frotschnig SM; Frantz S; Huber J; Eller P; Schgoer W; Foeger B; Patsch JR; Ritsch A
Atherosclerosis; 2009 Sep; 206(1):234-8. PubMed ID: 19268942
[TBL] [Abstract][Full Text] [Related]
23. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
[TBL] [Abstract][Full Text] [Related]
24. Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression.
Nicholson AC; Hajjar DP; Zhou X; He W; Gotto AM; Han J
Br J Pharmacol; 2007 Jul; 151(6):807-15. PubMed ID: 17549051
[TBL] [Abstract][Full Text] [Related]
25. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.
Igarashi J; Miyoshi M; Hashimoto T; Kubota Y; Kosaka H
Br J Pharmacol; 2007 Feb; 150(4):470-9. PubMed ID: 17220911
[TBL] [Abstract][Full Text] [Related]
26. Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36.
Han J; Zhou X; Yokoyama T; Hajjar DP; Gotto AM; Nicholson AC
Circulation; 2004 Feb; 109(6):790-6. PubMed ID: 14970117
[TBL] [Abstract][Full Text] [Related]
27. Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux.
Mulcahy JV; Riddell DR; Owen JS
Biochem J; 2004 Feb; 377(Pt 3):741-7. PubMed ID: 14570588
[TBL] [Abstract][Full Text] [Related]
28. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages.
Buechler C; Ritter M; Quoc CD; Agildere A; Schmitz G
Biochem Biophys Res Commun; 1999 Aug; 262(1):251-4. PubMed ID: 10448100
[TBL] [Abstract][Full Text] [Related]
30. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques.
Svensson PA; Englund MC; Snäckestrand MS; Hägg DA; Ohlsson BG; Stemme V; Mattsson-Hulten L; Thelle DS; Fagerberg B; Wiklund O; Carlsson LM; Carlsson B
BMC Cardiovasc Disord; 2005 Aug; 5():25. PubMed ID: 16122381
[TBL] [Abstract][Full Text] [Related]
31. Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).
Han J; Parsons M; Zhou X; Nicholson AC; Gotto AM; Hajjar DP
Circulation; 2004 Nov; 110(22):3472-9. PubMed ID: 15557368
[TBL] [Abstract][Full Text] [Related]
32. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis.
Trigatti BL; Krieger M; Rigotti A
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1732-8. PubMed ID: 12920050
[TBL] [Abstract][Full Text] [Related]
33. Scavenger receptor class B type I (SR-BI) and high-density lipoprotein metabolism: recent lessons from genetically manipulated mice.
Trigatti B; Rigotti A
Int J Tissue React; 2000; 22(2-3):29-37. PubMed ID: 10937352
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
